Rare Case of Campylobacter jejuni Bacteremia in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Comprehensive Evaluation of Clinical Management, Pathophysiology, and Public Health Implications
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Campylobacter jejuni bacteremia is rare, especially in immunocompetent individuals. This case highlights its occurrence in a child with acute lymphoblastic leukemia (ALL) undergoing chemotherapy, emphasizing risks for immunocompromised pediatric patients.
Area Of Science
- Medical Microbiology
- Pediatric Oncology
- Infectious Diseases
Background
- Campylobacter jejuni commonly causes gastroenteritis but rarely leads to systemic infections like bacteremia.
- Immunocompromised individuals, particularly those undergoing chemotherapy, are at higher risk for severe bacterial infections.
- Chemotherapy can compromise the mucosal barrier and immune system, facilitating bacterial translocation.
Purpose Of The Study
- To report a rare case of Campylobacter jejuni bacteremia in a pediatric patient with acute lymphoblastic leukemia (ALL).
- To emphasize the diagnostic challenges and treatment strategies for C. jejuni bacteremia in immunocompromised children.
- To highlight the importance of clinical awareness and laboratory support in managing severe Campylobacter infections.
Main Methods
- Case report of a 12-year-old girl with febrile neutropenia, mucositis, and diarrhea.
- Identification of C. jejuni using MALDI-TOF mass spectrometry from blood cultures.
- Antimicrobial susceptibility testing to guide treatment with erythromycin.
Main Results
- Successful identification of C. jejuni bacteremia after prolonged incubation of blood cultures.
- Demonstration of patient's sensitivity to erythromycin, leading to effective treatment.
- Complete recovery following a 10-day course of antibiotics.
Conclusions
- Chemotherapy-induced neutropenia and mucosal damage significantly increase the risk of C. jejuni bacteremia in pediatric ALL patients.
- Rapid diagnostics and susceptibility-guided therapy are crucial for managing this rare but severe infection.
- Heightened clinical vigilance and public health strategies are essential to protect vulnerable populations from severe Campylobacter infections.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...